Nodal T Follicular Helper Cell Lymphoma With Epstein–Barr Virus‐Positive Neoplastic T Cells Derived From Clonal Hematopoiesis

ABSTRACT Introduction Nodal T follicular helper cell lymphoma (nTFHL) with Epstein–Barr virus (EBV)‐positive neoplastic T cells is rare. Methods We report a woman with nTFHL and analyzed EBV‐infected cells using an immunobead‐based method and assessed somatic mutations in lymphoma and lymphoma‐uninvolved bone marrow by targeted sequencing. Results EBV DNA was enriched in the CD4‐positive fraction containing neoplastic T cells. Shared TET2 mutation was identified in both lymphoma and bone marrow, whereas additional TET2 and RHOA G17V mutations were restricted to the lymphoma. Conclusion These findings support a stepwise model of EBV‐positive nTFHL arising from TET2 ‐mutated clonal hematopoiesis with subsequent acquisition of a RHOA mutation. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.

Authors

Institutions

Publication Details

Journal
eJHaem
Published
2026-10-28
DOI
https://doi.org/10.1002/jha2.70449
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nodal T Follicular Helper Cell Lymphoma With Epstein–Barr Virus‐Positive Neoplastic T Cells Derived From Clonal Hematopoiesis

Hayato Maruoka, Yuka Torii, Ryusuke Yamamoto, Yumi Shiroishi et al.
eJHaem
Lymphoma Diagnosis and Treatment
article

Nodal T Follicular Helper Cell Lymphoma With Epstein–Barr Virus‐Positive Neoplastic T Cells Derived From Clonal Hematopoiesis

Hayato Maruoka, Yuka Torii, Ryusuke Yamamoto, Yumi Shiroishi, Hiroshi Kimura, Nobuhiro Hiramoto, Tadakazu Kondo, Masashi Nishikubo, Yuya Nagai, Yoshimitsu Shimomura, Seishi Ogawa, Yasuhito Nannya, Daisuke Yamashita, Daichi Kishi
article en

Abstract

ABSTRACT Introduction Nodal T follicular helper cell lymphoma (nTFHL) with Epstein–Barr virus (EBV)‐positive neoplastic T cells is rare. Methods We report a woman with nTFHL and analyzed EBV‐infected cells using an immunobead‐based method and assessed somatic mutations in lymphoma and lymphoma‐uninvolved bone marrow by targeted sequencing. Results EBV DNA was enriched in the CD4‐positive fraction containing neoplastic T cells. Shared TET2 mutation was identified in both lymphoma and bone marrow, whereas additional TET2 and RHOA G17V mutations were restricted to the lymphoma. Conclusion These findings support a stepwise model of EBV‐positive nTFHL arising from TET2 ‐mutated clonal hematopoiesis with subsequent acquisition of a RHOA mutation. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.

eJHaemVol. 7(6)
Kyoto University (JP), Kobe Medical Center (JP), Kobe City Medical Center General Hospital (JP), Institute for the Advanced Study of Human Biology, Kyoto University (JP), Institute of Medical Science, The University of Tokyo (JP), Nagoya University (JP), The University of Tokyo (JP)
Openalex Percentile: Top 12%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon